文献速递类风湿关节炎

短信/电子邮件提醒能否提高接受抗TNF治疗的类风湿关节炎患者的流感疫苗接种率:ART电子队列中的嵌套随机对照试验

Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在法国全国多中心前瞻性ART电子队列中嵌套随机对照试验,将446例接受抗TNF治疗的类风湿关节炎患者按年龄分层1:1随机分组,干预组接受短信和/或电子邮件定期提醒接种流感疫苗。干预组接种率116/158(73%) vs 对照组105/167(63%),相对风险1.08(95%CI 0.95-1.23),提醒未显著提高接种率;年龄≥65岁(OR 6.25;95%CI 2.88-13.60)和既往接种流感疫苗(OR 7.81;95%CI 4.36-14.02)与更高接种率相关。

要点

  • 短信和/或电子邮件提醒未显著提高抗TNF治疗的类风湿关节炎患者流感疫苗接种率(相对风险1.08;95%CI 0.95-1.23)。
  • 年龄≥65岁(OR 6.25;95%CI 2.88-13.60)和既往接种流感疫苗(OR 7.81;95%CI 4.36-14.02)与更高接种率相关。
  • COVID-19大流行前后流感疫苗接种覆盖率无差异(72% vs 72%;95%CI -8%至8%)。

核心结论

  • 短信和/或电子邮件提醒未显著提高本队列的流感疫苗接种率。
  • COVID-19大流行未实质影响流感疫苗接种覆盖率。
  • 作者认为结果可能被本已较高的疫苗接种覆盖率所抵消。

研究设计与样本

  • 本研究为ART电子队列中的嵌套随机对照试验;ART电子队列是正在进行的法国全国多中心前瞻性队列,纳入接受抗TNF治疗的类风湿关节炎患者。
  • 2021年10月至2022年4月期间共446例参与者被随机分组,按年龄分层1:1随机,干预组224例、对照组222例。
  • 干预措施为在疫苗接种活动期间通过短信和/或电子邮件定期提醒接种流感疫苗;研究结束时所有参与者收到问卷。
  • 主要结局为流感疫苗接种覆盖率;次要结局包括COVID-19大流行前后的疫苗接种覆盖率及与接种相关的因素。

主要发现

  • 325例(73%)报告了接种状态,其中221例(68%)接种了流感疫苗:干预组116/158(73%) vs 对照组105/167(63%),相对风险1.08(95%CI 0.95-1.23)。
  • COVID-19大流行前后疫苗接种覆盖率无差异(72% vs 72%;95%CI -8%至8%)。
  • 年龄≥65岁与更高接种率相关(OR 6.25;95%CI 2.88-13.60)。
  • 纳入前数年既往接种流感疫苗与更高接种率相关(OR 7.81;95%CI 4.36-14.02)。

局限性

  • 作者认为结果可能被本已较高的疫苗接种覆盖率所抵消。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objectives of this study were to evaluate the effectiveness of short message service (SMS) and/or email reminders in improving influenza vaccination coverage rates among RA patients treated with anti-TNF therapies, and to identify factors associated with vaccination. METHODS: This study was a nested randomized controlled trial in the ART e-cohort, an ongoing French nationwide multicentre prospective cohort of RA patients treated with anti-TNF therapy. Patients were 1:1 randomized, with stratification on age. The intervention consisted of regular reminders via SMS and/or emails to get vaccinated against influenza during the vaccination campaign. At the end, all participants received a questionnaire. The primary outcome was influenza vaccination coverage. Secondary outcomes included the vaccination coverage before and after the COVID-19 pandemic, and factors associated with vaccination. RESULTS: Between October 2021 and April 2022, 446 participants were randomized (224 to the intervention group and 222 to the control group). Among them, 325 (73%) reported their vaccination status and 221 (68%) were vaccinated against influenza: 116/158 (73%) in the intervention group, vs 105/167 (63%) in the control group (relative risk 1.08; 95% CI 0.95-1.23). The vaccination coverage before and after the COVID-19 pandemic did not differ (72% vs 72%; 95% CI -8% to 8%). Age ≥65 years [odds ratio (OR) 6.25; 95% CI 2.88-13.60] and previous influenza vaccination in the years before inclusion (OR 7.81; 95% CI 4.36-14.02) were associated with higher rates of vaccination. CONCLUSION: SMS and/or e-mail reminders did not significantly improve influenza vaccination rates in our cohort. The COVID-19 pandemic did not substantially impact the influenza vaccination coverage. Our results might be counterbalanced by an already high vaccination coverage. TRIAL REGISTRATION: ClinicalTrials.gov, http://clinicaltrials.gov, NCT05220423, NCT03062865.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Nguyen Y, Baron G, Hamamouche N, et al. Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort. Rheumatology (Oxford). 2025. PMID: 39576675. doi:10.1093/rheumatology/keae599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。